CytoDyn Inc.
看多

CYDY: An OTC Biotech with several drugs and treatment under

148
development broke out huge last week with its cancer and HIV drug. With these companies, I think it is more news driven than chart driven.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。